These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17054574)

  • 21. [Psychotropic drug-induced myoclonus].
    Brogmus KE; Lesch A
    Psychiatr Prax; 1995 Mar; 22(2):77-9. PubMed ID: 7761544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticholinergic drug-induced delirium in an elderly Alzheimer's dementia patient.
    Gareri P; De Fazio P; Cotroneo A; Lacava R; Gallelli L; De Fazio S; De Sarro G
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():199-206. PubMed ID: 17317453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical therapy of depressive syndromes with Noxiptilin].
    Hohnbaum M; Sattes H
    Arzneimittelforschung; 1970 Jul; 20(7):940-3. PubMed ID: 5536065
    [No Abstract]   [Full Text] [Related]  

  • 24. Choreatic symptoms during and after treatment with paliperidone and escitalopram.
    Hüther R; Gebhart C; Mirisch S; Bäuml J; Förstl H
    Pharmacopsychiatry; 2008 Sep; 41(5):203-4. PubMed ID: 18763225
    [No Abstract]   [Full Text] [Related]  

  • 25. Delirium due to a drug-drug interaction of lithium and an NSAID.
    Faaij RA; Ziere G; Zietse R; Van der Cammen TJ
    J Nutr Health Aging; 2009 Mar; 13(3):275-6. PubMed ID: 19262967
    [No Abstract]   [Full Text] [Related]  

  • 26. [Recurring depression].
    Lôo H
    Encephale; 2005 Oct; 31 Pt 2():S19-21. PubMed ID: 16673698
    [No Abstract]   [Full Text] [Related]  

  • 27. Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI.
    Nordlund A; Rolstad S; Klang O; Lind K; Pedersen M; Blennow K; Edman A; Hansen S; Wallin A
    J Int Neuropsychol Soc; 2008 Jul; 14(4):582-90. PubMed ID: 18577287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delirium caused by a drug-drug interaction between bupropion and risperidone.
    Lu YY; Hsueh JH; Wei IH; Huang CC
    J Clin Psychopharmacol; 2014 Feb; 34(1):161-2. PubMed ID: 24346746
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial.
    Blumberger DM; Mulsant BH; Emeremni C; Houck P; Andreescu C; Mazumdar S; Whyte E; Rothschild AJ; Flint AJ; Meyers BS
    J Psychiatr Res; 2011 Jul; 45(7):896-901. PubMed ID: 21300377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study.
    Li G; Sokal I; Quinn JF; Leverenz JB; Brodey M; Schellenberg GD; Kaye JA; Raskind MA; Zhang J; Peskind ER; Montine TJ
    Neurology; 2007 Aug; 69(7):631-9. PubMed ID: 17698783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Carbamazepine in the treatment in psychiatric disorders based on retrospective clinical study].
    Afeltowicz Z; Majkowicz M; Michalik K; Radziwiłłowicz P; Sowiński P; Smoczyński S; Trzebiatowska IA
    Psychiatr Pol; 2002; 36(6 Suppl):303-10. PubMed ID: 12647453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of therapy-refractory depressions].
    Pöldinger W; Alac S; Krebs-Roubicek E
    Act Nerv Super (Praha); 1982 May; 24(2):55-62. PubMed ID: 6125075
    [No Abstract]   [Full Text] [Related]  

  • 33. Atypical antipsychotic augmentation in treatment-resistant major depressive disorder.
    Delgado A; Ehert M
    Conn Med; 2011 Mar; 75(3):153-6. PubMed ID: 21500706
    [No Abstract]   [Full Text] [Related]  

  • 34. Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.
    Hansson O; Buchhave P; Zetterberg H; Blennow K; Minthon L; Warkentin S
    Neurobiol Aging; 2009 Feb; 30(2):165-73. PubMed ID: 17646035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.
    Mohamed S; Leslie DL; Rosenheck RA
    J Clin Psychiatry; 2009 Jun; 70(6):906-12. PubMed ID: 19422760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptoms of agitated depression and/or akathisia.
    Peitl MV; Prološčić J; Blažević-Zelić S; Skarpa-Usmiani I; Peitl V
    Psychiatr Danub; 2011 Mar; 23(1):108-10. PubMed ID: 21448111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interest of CSF beta-amyloid1-42 and t-tau protein level determinations for the diagnosis of Alzheimer's disease].
    Smach MA; Charfeddine B; Lammouchi T; Dridi H; Ben Othman L; Bennamou S; Limem K
    Ann Biol Clin (Paris); 2008; 66(5):531-5. PubMed ID: 18957342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment.
    Stefani A; Martorana A; Bernardini S; Panella M; Mercati F; Orlacchio A; Pierantozzi M
    J Neurol Sci; 2006 Dec; 251(1-2):124-8. PubMed ID: 17097109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychogeriatrics.
    Shamoian CA
    Neurol Clin; 1984 Feb; 2(1):155-72. PubMed ID: 6150428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biomarkers in cerebrospinal fluid and blood in memory complaints].
    Zetterberg H; Andreasen N; Blennow K
    Lakartidningen; 2009 May 13-19; 106(20):1386-9. PubMed ID: 19585836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.